Airbus Completes Quarkslab Buy to Deepen European Sovereign Cyber
What happened On 1 October 2026, Airbus Defence and Space said it had finalised the acquisition of Quarkslab, a French cybersecurity company, after receiving the required regulatory approvals. The deal is framed as another step in Airbus’ strategy to deepen its role as a trusted sovereign partner for French authorities while widening its European cybersecurity […]
Stryten Energy Completes C&D Trojan Deal to Scale North American Battery Platform
What happened On 1 October 2026, Alpharetta-based Stryten Energy LLC said it had completed its purchase of C&D Technologies, Inc. and Trojan Battery Company, LLC. The close unites three brands under one company that designs, makes, and distributes advanced lead, lithium, and vanadium redox flow batteries for transportation, golf and marine, specialty motive, industrial, critical […]
Wandercraft Acquires Ekso Bionics to Scale Medical Exoskeleton Platform
What happened On 1 October 2026, Paris-based robotics company Wandercraft said it had acquired Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation. Both boards unanimously approved the transaction, which was signed and closed at the same time. Financial terms were not disclosed. Wandercraft framed the combination as a leading medical exoskeleton platform with […]
CMA CGM Closes $1.4 Billion FedEx Supply Chain Deal for CEVA
What happened On 1 October 2026 the CMA CGM Group said it had completed the purchase of FedEx Supply Chain, a subsidiary of FedEx Corp., at an enterprise value of 1.4 billion dollars. The unit moves into CEVA Logistics, the group’s logistics subsidiary, and closes a deal the parties first announced on 1 July 2026. […]
onsemi Revises Synaptics Merger to $123 a Share in Cash, About $5.7 Billion
What happened On 1 October 2026, onsemi and Synaptics Incorporated said they had amended the merger agreement first signed on 25 June 2026. The revision follows an unsolicited competing proposal from a third party. Under the new terms, onsemi will acquire Synaptics for 123 dollars per share in cash, for an aggregate value of about […]
Ampol Agrees AUD 225 Million Deal to Acquire Evie Networks EV Charging Platform
What happened Ampol Limited has moved to deepen its stake in Australia’s public electric vehicle charging market. On 1 October 2026 the ASX-listed fuel and convenience retailer said its subsidiary Ampol Energy Pty Ltd signed a share sale agreement to buy 100% of Fast Cities Australia Pty Ltd, which trades as Evie Networks, for a […]
Avio USA Breaks Ground on Virginia Solid Rocket Motor Plant
What happened Avio USA has broken ground on its first United States manufacturing plant, an approximately 900,000-square-foot solid rocket motor facility in Hurt, Virginia. The site sits inside the Southern Virginia Multimodal Park in Pittsylvania County and is intended to produce solid rocket motors for U.S. tactical missile and munitions programs. Parent company Avio S.p.A., […]
Hormel Foods to Acquire Brakebush in $1.055 Billion Value-Added Chicken Deal
What happened Hormel Foods Corporation has signed a definitive agreement to buy Brakebush Brothers, LLC, a Westfield, Wisconsin-based value-added chicken company, from the Brakebush family for about $1.055 billion. The deal is aimed at the first quarter of Hormel Foods fiscal 2027, pending customary closing conditions and regulatory approval. Brakebush is a non-vertically integrated chicken […]
Shinko Electric to Acquire JDI Mobara Plant for Advanced Chip Packaging
What happened On 30 September 2026, Semiconductor & Electronics packaging specialist Shinko Electric Industries signed a definitive purchase agreement for Japan Display (JDI) Mobara plant in Mobara City, Chiba Prefecture. The idle display fab – land, buildings and ancillary facilities on roughly 373,483 square meters – will be handed over around 31 March 2027. Shinko […]
Fresenius Takes Full Ownership of mAbxience Biosimilars Platform
Fresenius has closed the buyout of the minority stake in mAbxience, turning a four-year majority partnership into a fully owned biosimilars and biologics manufacturing platform inside Fresenius Kabi. For hospital buyers, payers, and rival CDMO and biosimilar developers, the move is less about a fresh entry and more about who controls capacity, launch timing, and […]